SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,851,000 | -7.5% | 4,000,000 | +14.3% | 0.21% | +18.4% |
| Q1 2022 | $4,165,000 | -57.4% | 3,500,000 | +16.7% | 0.17% | -34.3% |
| Q4 2021 | $9,780,000 | +9.4% | 3,000,000 | +50.0% | 0.26% | +32.5% |
| Q3 2021 | $8,940,000 | -3.5% | 2,000,000 | +17.6% | 0.20% | +6.4% |
| Q2 2021 | $9,265,000 | +20.8% | 1,700,000 | +65.9% | 0.19% | +39.3% |
| Q1 2021 | $7,667,000 | -5.8% | 1,025,000 | +36.7% | 0.14% | -22.9% |
| Q4 2020 | $8,138,000 | +97.8% | 750,000 | +61.1% | 0.18% | +75.0% |
| Q3 2020 | $4,115,000 | -21.2% | 465,500 | -5.0% | 0.10% | -31.5% |
| Q2 2020 | $5,223,000 | +74.0% | 490,000 | -3.2% | 0.15% | +15.0% |
| Q1 2020 | $3,001,000 | – | 506,138 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |